Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Weak Q3 For Biocon, All Eyes On Biosimilars Approval Flow

Jan 25 2018

• By Anju Ghangurde

Jigsaw — APPROVALS FOR BIOCON'S BIOSIMILARS COULD LIFT GROWTH

Related Content

Keeping Track: FDA Hands Out Complete Responses, Expedited Pathway Designations

Oct 15 2017

More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab

Dec 29 2017

Biocon/Fujifilm Enter Lantus Biosimilar Fray In Japan

Mar 29 2016

Riding The Next Wave Of Biosimilars: Sandoz To Link Up With India's Biocon

Jan 18 2018

Related Companies

Biocon, Ltd.

Viatris Inc.

Genentech, Inc.

Novartis AG

Biocon, Ltd.

Additional Topics

India Asia Pacific Commercial Companies Sales & Earnings

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window